Elizabeth G. Nabel, Director at Moderna, Inc. (MRNA), sold 30,000 shares at $66.00 ($2.0M) on 2020-05-12, disclosed to the SEC on 2020-06-04.
Open-market sale of $2.0M MRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.